Athersys in brief
Athersys is a listed company in the Biotechnology industry, based in Cleveland, Ohio, USA. It was founded in 1995. Its last known market value was $14 M (July 2023); there is no current figure. In its latest reported year it had sales of $1 M and a net loss of $79 M. It employs about 83 people. Its shares trade under the symbol ATHX (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Athersys
Athersys is a Clinical Stage Biotechnology company developing novel and proprietary best in class therapies designed to extend and enhance the quality of human life. The company annual revenue is 1.4 million USD and 75 employees as on 2020. The headquarters is in USA.
Athersys timeline
- 1995
- 🏁· approximateFounded
- 2005
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2007
- 🔔· approximateInitial public offering on Nasdaq as ATHX
Events of Athersys from Wikidata and SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #3,259 (Jan 2020) · #2,842 (Jan 2021) · #3,815 (Jan 2022) · #5,440 (Dec 2022) · #5,319 (Jul 2023)
Key ratios
- P/E ratio
- n/m (loss)
- Price / sales
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin
- -5621.4%
- Operating margin
- —
- Return on equity
- —
- Liabilities / assets
- —
- Revenue per employee
- $17 K
- Profit per employee
- $-948 K
Annual results
- Revenue
- $1 M
- Operating income
- —
- Net income
- $-79 M
How Athersys compares in Biotechnology
- Revenue$1 M · higher than 28% of 647
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Athersys🇺🇸 | $14 M | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Market cap:
- Jul 30, 2023 (last known)
- Employees:
- 2019
- Profile updated:
- Nov 15, 2026
Figures from value.today research, Wikidata.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Athersys? Verify and update this profile — free
Show Athersys's ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.